These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35715285)

  • 1. Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study.
    Bakouny Z; Labaki C; Bhalla S; Schmidt AL; Steinharter JA; Cocco J; Tremblay DA; Awad MM; Kessler A; Haddad RI; Evans M; Busser F; Wotman M; Curran CR; Zimmerman BS; Bouchard G; Jun T; Nuzzo PV; Qin Q; Hirsch L; Feld J; Kelleher KM; Seidman D; Huang H; Anderson-Keightly HM; El Zarif T; Alaiwi SA; Champagne C; Rosenbloom TD; Stewart PS; Johnson BE; Trinh Q; Tolaney SM; Galsky MD; Choueiri TK; Doroshow DB
    Ann Oncol; 2022 Aug; 33(8):836-844. PubMed ID: 35715285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations.
    George TJ; Lin TL; Adrales Bentz T; Grant S; Houston CM; Nashawati MA; Pappu B; Peck H; Zafirovski A; Kerstann K; LoRusso P; Schnatterly A; Hofacker J; Cameron K; Honeycutt H; Werner TL
    JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37467065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer Centers.
    Sundquist S; Kato D; Xu RY; Schoales J; Kulendran S; Dancey JE
    Curr Oncol; 2022 Mar; 29(4):2435-2441. PubMed ID: 35448171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 Pandemic on Cancer Clinical Trials: Alliance for Clinical Trials in Oncology Experience (Alliance A152022).
    Snyder RA; Hillman SL; Marcotte V; Paskett ED; George S; Hahn O; Mandrekar SJ
    J Clin Trials; 2024; 14(5):. PubMed ID: 39296880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COVID-19 pandemic and new clinical trial activations.
    Unger JM; Xiao H
    Trials; 2021 Apr; 22(1):260. PubMed ID: 33832534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
    Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
    JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study.
    Graetz D; Agulnik A; Ranadive R; Vedaraju Y; Chen Y; Chantada G; Metzger ML; Mukkada S; Force LM; Friedrich P; Lam C; Sniderman E; Bhakta N; Hessissen L; Dalvi R; Devidas M; Pritchard-Jones K; Rodriguez-Galindo C; Moreira DC
    Lancet Child Adolesc Health; 2021 May; 5(5):332-340. PubMed ID: 33675698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
    Shimizu T; Kim DW; Loong HH; Lin CC; Ng MC; Yamamoto N; Ma B; Tan DS
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):388-395. PubMed ID: 33502085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2010 Nov; 16(22):5557-63. PubMed ID: 21062929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials.
    Smeltzer MP; Scagliotti GV; Wakelee HA; Mitsudomi T; Roy UB; Clark RC; Arndt R; Pruett CD; Kelly KL; Ujhazy P; Johnson ML; Eralp Y; Barrios CH; Barlesi F; Hirsch FR; Bunn PA;
    J Thorac Oncol; 2022 May; 17(5):651-660. PubMed ID: 35183774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality.
    Unger JM; Stires H; Levit LA; Stewart M; McKelvey BA; Canin B; Dressler E; Flaherty K; Fredette P; Jones L; McCann P; Miller T; Onitilo AA; Palmieri F; Patel T; Paul R; Smith GL; Bruinooge SS; Garrett-Mayer E; Lei XJ; Alva A; Schenkel C
    JCO Oncol Pract; 2023 Oct; 19(10):907-916. PubMed ID: 37643386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers.
    Prindiville SA; Sarosy GA; Loose D; Ciolino H; Doroshow JH
    Cancer J; 2022 Mar-Apr 01; 28(2):111-117. PubMed ID: 35333495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
    Arndt V; Doege D; Fröhling S; Albers P; Algül H; Bargou R; Bokemeyer C; Bornhäuser M; Brandts CH; Brossart P; Brucker SY; Brümmendorf TH; Döhner H; Gattermann N; Hallek M; Heinemann V; Keilholz U; Kindler T; von Levetzow C; Lordick F; Neumann UP; Peters C; Schadendorf D; Stilgenbauer S; Zander T; Zips D; Braun D; Seufferlein T; Nettekoven G; Baumann M
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):913-919. PubMed ID: 36241862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of childhood cancer in Canada during the COVID-19 pandemic.
    Pelland-Marcotte MC; Xie L; Barber R; Elkhalifa S; Frechette M; Kaur J; Onysko J; Bouffet E; Fernandez CV; Mitchell D; Rayar M; Randall A; Stammers D; Larouche V; Airhart A; Fidler-Benaoudia M; Cohen-Gogo S; Sung L; Gibson P
    CMAJ; 2021 Nov; 193(47):E1798-E1806. PubMed ID: 34844937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19.
    Mullangi S; Aviki EM; Chen Y; Robson M; Hershman DL
    JAMA Netw Open; 2022 Jul; 5(7):e2224296. PubMed ID: 35900758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic.
    Yeboa DN; Akinfenwa CA; Nguyen J; Amaya D; de Gracia B; Ning M; Cox V; De B; Smith BD; Lin L; Beddar S; Hoang H; Koong A; Liao Z
    Adv Radiat Oncol; 2021; 6(3):100676. PubMed ID: 33686374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic.
    Unger JM; Xiao H; LeBlanc M; Hershman DL; Blanke CD
    JAMA Netw Open; 2021 Jul; 4(7):e2118433. PubMed ID: 34323986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.